Newswire (Published: Wednesday, November 6, 2019, Received: Wednesday, November 6, 2019, 5:23:39 PM CST)
Word Count: 213
2019 NOV 06 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Data detailed on Oncology - Prostate Cancer have been presented. According to news reporting out of Oklahoma City, Oklahoma, by NewsRx editors, the research stated, “The management of high-risk prostate cancer is evolving. Currently, most decisions are based on traditional factors such as tumor grade and stage.”
Our news journalists obtained a quote from the research from the University of Oklahoma, “However, we are in a state of evolution. A new understanding of the value of both genetic and somatic germline testing is upon us.”
According to the news editors, the research concluded: “Perhaps even more exciting is the recognition that genomic testing can and should be moved up in certain high-risk patients so more effective and targeted therapy can be applied earlier in the disease state.”
For more information on this research see: Urology perspective on the expanding world of germline testing for prostate cancer. The Canadian Journal of Urology, 2019;26(5S2):5-6.
Our news journalists report that additional information may be obtained by contacting M.S. Cookson, Dept. of Urology, University of Oklahoma, Oklahoma City, Oklahoma, United States.
(Our reports deliver fact-based news of research and discoveries from around the world.)
University of Oklahoma
Science and Technology
Health and Wellness
Medical Conditions and Diseases
Men's Health Issues
Medical Specialties and Practices